Načítá se...
Quality Assurance in Biobanking for Pre-Clinical Research
It is estimated that not less than USD 28 billion are spent each year in the USA alone on irreproducible pre-clinical research, which is not only a fundamental loss of investment and resources but also a strong inhibitor of efficiency for upstream processes regarding the translation towards clinical...
Uloženo v:
| Vydáno v: | Transfus Med Hemother |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger GmbH
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5073593/ https://ncbi.nlm.nih.gov/pubmed/27781023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000448254 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|